These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 27312859

  • 1. The anti-estrogenic activity of indole-3-carbinol in neonatal rat osteoblasts is associated with the estrogen receptor antagonist 2-hydroxyestradiol.
    Enríquez J, Velázquez-Cruz R, Parra-Torres A, Gutiérrez-Sagal R, Larrea F.
    J Endocrinol Invest; 2016 Oct; 39(10):1149-58. PubMed ID: 27312859
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Equol promotes rat osteoblast proliferation and differentiation through activating estrogen receptor.
    Wang J, Xu J, Wang B, Shu FR, Chen K, Mi MT.
    Genet Mol Res; 2014 Jul 04; 13(3):5055-63. PubMed ID: 25061730
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Direct action of naturally occurring estrogen metabolites on human osteoblastic cells.
    Robinson JA, Waters KM, Turner RT, Spelsberg TC.
    J Bone Miner Res; 2000 Mar 04; 15(3):499-506. PubMed ID: 10750564
    [Abstract] [Full Text] [Related]

  • 7. The synthetic progestin, gestodene, affects functional biomarkers in neonatal rat osteoblasts through an estrogen receptor-related mechanism of action.
    Enríquez J, García G, Herrero B, Larrea F.
    Endocr Res; 2017 Nov 04; 42(4):269-280. PubMed ID: 28328298
    [Abstract] [Full Text] [Related]

  • 8. Neonatal rat osteoblasts bioconvert testosterone to non-phenolic metabolites with estrogen-like effects on bone cell proliferation and differentiation.
    Enríquez J, Larrea F, Santillán R, Hernández Á, Herrero B, Pérez-Palacios G, Lemus AE.
    Horm Mol Biol Clin Investig; 2013 Jun 04; 13(3):41-9. PubMed ID: 25436712
    [Abstract] [Full Text] [Related]

  • 9. Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells.
    Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S.
    J Nutr; 2000 Dec 04; 130(12):2927-31. PubMed ID: 11110848
    [Abstract] [Full Text] [Related]

  • 10. Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer.
    Ashok BT, Chen YG, Liu X, Garikapaty VP, Seplowitz R, Tschorn J, Roy K, Mittelman A, Tiwari RK.
    Eur J Cancer Prev; 2002 Aug 04; 11 Suppl 2():S86-93. PubMed ID: 12570340
    [Abstract] [Full Text] [Related]

  • 11. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.
    Leong H, Firestone GL, Bjeldanes LF.
    Carcinogenesis; 2001 Nov 04; 22(11):1809-17. PubMed ID: 11698343
    [Abstract] [Full Text] [Related]

  • 12. Daidzein stimulates osteogenesis facilitating proliferation, differentiation, and antiapoptosis in human osteoblast-like MG-63 cells via estrogen receptor-dependent MEK/ERK and PI3K/Akt activation.
    Jin X, Sun J, Yu B, Wang Y, Sun WJ, Yang J, Huang SH, Xie WL.
    Nutr Res; 2017 Jun 04; 42():20-30. PubMed ID: 28633868
    [Abstract] [Full Text] [Related]

  • 13. Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism.
    Yoshida M, Katashima S, Ando J, Tanaka T, Uematsu F, Nakae D, Maekawa A.
    Carcinogenesis; 2004 Nov 04; 25(11):2257-64. PubMed ID: 15240508
    [Abstract] [Full Text] [Related]

  • 14. The Non-Aromatic Δ5-Androstenediol Derivative of Dehydroepiandrosterone Acts as an Estrogen Agonist in Neonatal Rat Osteoblasts through an Estrogen Receptor α-related Mechanism.
    Langley E, Velazquez-Cruz R, Parra-Torres A, Enríquez J.
    Endocr Res; 2019 Aug 04; 44(3):87-102. PubMed ID: 30580653
    [Abstract] [Full Text] [Related]

  • 15. Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells.
    Gupta M, McDougal A, Safe S.
    J Steroid Biochem Mol Biol; 1998 Dec 04; 67(5-6):413-9. PubMed ID: 10030690
    [Abstract] [Full Text] [Related]

  • 16. 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.
    Nguyen HH, Lavrenov SN, Sundar SN, Nguyen DH, Tseng M, Marconett CN, Kung J, Staub RE, Preobrazhenskaya MN, Bjeldanes LF, Firestone GL.
    Chem Biol Interact; 2010 Aug 05; 186(3):255-66. PubMed ID: 20570586
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds.
    Niwa T, Swaneck G, Bradlow HL.
    Steroids; 1994 Sep 05; 59(9):523-7. PubMed ID: 7846734
    [Abstract] [Full Text] [Related]

  • 19. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture.
    Qu Q, Perälä-Heape M, Kapanen A, Dahllund J, Salo J, Väänänen HK, Härkönen P.
    Bone; 1998 Mar 05; 22(3):201-9. PubMed ID: 9514212
    [Abstract] [Full Text] [Related]

  • 20. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL.
    Mol Endocrinol; 2006 Dec 05; 20(12):3070-82. PubMed ID: 16901971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.